Omada Health, Inc. (OMDA) Stock Price & Analysis
Omada Health, Inc. (OMDA) rose 2.15% to USD 22.77 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
OMDA last closed at USD 22.77; the session ranged USD 21.86–22.97 on volume of 877,387 shares. Market capitalization is —, with a 52-week range of USD 10.28–26.92 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 22.77 |
|---|---|
| Change | ▲ 2.15% (up) |
| Previous Close | USD 22.77 |
| Open | USD 22.77 |
| Day Range | USD 21.86 – 22.97 |
| 52-Week Range | USD 10.28 – 26.92 |
| Volume | 877,387 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (OMDA)
Nexqual's technical model rates OMDA "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 45.59 (neutral) |
| vs SMA50 | Above (USD 22.67) |
| MACD | 0.27 (positive) |
From Omada Health, Inc.'s Latest SEC 10-K Filing (filed 2026-03-06)
Key Strengths & Strategy (as disclosed to the SEC)
- Department of Health and Human Services ("HHS") may be subject to significant civil, criminal, and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance.
- Class I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the FDA's General Controls for medical devices, which include compliance with the applicable portions of the Quality Management System Regulation ("QMSR"), facility registration and product listing, reporting of adverse medical events, and truthful and non-misleading labeling, advertising, and promotional materials.
- As of December 31, 2025, we had more than 2,000 customers, over 886,000 total members enrolled in one or more programs, and had supported nearly two million members since launch.
- We Deliver Outcome s: We have demonstrated clinical outcomes and economic value across our multi- condition platform, including 30 published, peer-reviewed studies as of December 31, 2025, which allow us to improve our programs and serve as a key differentiator.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HNGE | Hinge Health, Inc. | USD 92.37 | ▲ 0.57% |
| CHYM | Chime Financial, Inc. | USD 33.76 | ▲ 1.05% |
| ETOR | eToro Group Ltd. | USD 32.47 | ▲ 1.95% |
| MNTN | MNTN, Inc. | USD 12.95 | ▼ 1.37% |
| HROW | Harrow, Inc. | USD 38.54 | ▼ 1.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.